Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?
about
Renal replacement therapy in acute kidney injury: controversy and consensusAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.Citrate anticoagulation in the ICU: the Leeds experience.Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needsRegional citrate anticoagulation for RRTs in critically ill patients with AKI.Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study.Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.Simplified Citrate Anticoagulation for CRRT Without Calcium ReplacementRegional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysisCitrate anticoagulation for CRRT: don't always trust the postfilter iCa results!Long-term remote organ consequences following acute kidney injury.Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solutionContinuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational studyEffects of fresh frozen plasma, Ringer's acetate and albumin on plasma volume and on circulating glycocalyx components following haemorrhagic shock in rats.Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluidBench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.Good-bye CRRT, here comes SLED? ... not so fast!Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study.Year in review 2012: Critical Care--Nephrology.Citrate modulates lipopolysaccharide-induced monocyte inflammatory responses.The intensive care medicine agenda on acute kidney injury.Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility.A method for deciding the optimal anticoagulant infusion dose for blood purification therapy.Analysis of the Alarms From a Blood Purification Machine During Continuous Haemodiafiltration.Hemofiltration induces generation of leukocyte-derived CD31+/CD41- microvesicles in sepsis.Lactate clearance and metabolic aspects of continuous high-volume hemofiltration.Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis.Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy.Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin.Complications of regional citrate anticoagulation: accumulation or overload?Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience.A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost.Stability of citrate and calcium dosing in citrate renal replacement therapy.Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunctionThe Novel PrisMax Continuous Renal Replacement Therapy System in a Multinational, Multicentre Pilot SettingAnticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit
P2860
Q26998864-0C44184F-E90A-457B-AB71-14D2C4722FF2Q30234560-379854BF-67DA-457D-9DF1-724BF97D4DEBQ33426850-140180D8-BB2B-4D66-9382-13B07B980B68Q33435298-C65E127D-A6ED-430B-B1BA-ABECC3C495B7Q33587210-B613712C-4FBE-46AE-AE60-8C862C6CC2E0Q34629661-806AA340-9780-4CAE-97A6-4E4A88860133Q34676665-92DC9599-D515-40E4-81DC-6288B7F40C49Q35190273-40A352FA-4059-4F07-8800-C8AF874628F7Q35806341-079E2C60-2F58-4857-A69B-A1299A81812AQ36017130-85BDAA49-D9DD-45A7-AF64-DBFA72980DC4Q36285489-89B24117-EE8E-4A2F-9FB9-4545F867D056Q36346759-502E02F1-BDCA-4040-AA44-32745AF87DD4Q36424776-C3BE262C-1612-4C41-B91C-58278AE1BF51Q36633751-1D91A264-9D62-48AA-96F0-00CB41363656Q36634057-19908374-4BD6-42E7-947A-C09AD3EE4244Q36650725-FA3F688A-7B85-44E9-8EDD-7E1DA1A0412CQ36801142-22660E23-6977-47C0-A440-36D83654D17FQ36902584-B7B17A8A-A0C0-4DA4-A7D5-F9F0656563C1Q36902623-7A5F9D26-FC3B-443E-97D3-D6B24B0A919AQ37714565-58EDC452-2F92-419C-B674-C88875DFED97Q38165354-734F62B6-FFE6-40FC-843E-D51F15F7517AQ38916731-CDFACC53-BEB5-4EEC-AE3B-BB354ED08518Q39110696-8E2F5B64-9E63-4165-85D5-4638F8A515B0Q39177500-7DE9B1D8-46D0-453D-9699-9EC0109A9C33Q39447145-0D7218EE-6D8B-4788-80F9-77511BB5E2E9Q41581422-13871AD2-C392-4B8C-8EA7-D9EE2E9C1991Q41605422-8894A9BD-8402-4029-A676-CA67A44DB2C1Q42392718-9391126C-E303-46D5-9B9D-33CD121A70F2Q45266817-D78FB941-C950-480C-97E8-28383189B5C3Q45782134-0EADF923-E157-475F-8A09-A43B20781D67Q45894727-81B7D968-98D7-4D63-A3D6-337236FEDDECQ46518144-14654817-58AB-43B2-9AB1-BB045FF61621Q50635510-3C0C2E58-A5EF-4238-8844-F02E7777E613Q52333189-70962402-417E-4D69-BCD4-A136C7585A40Q54215828-C6B485E5-4CF0-4540-A559-EA94D9F43E45Q56589994-B895E8E9-AE68-467D-825D-20C787058F72Q57322375-B7F5EA2C-FFAA-48A4-ABB5-DE19469427B5Q59100879-F2C0E631-60F7-4BC7-A64D-E7F7F8FC7F99
P2860
Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@ast
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@en
type
label
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@ast
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@en
prefLabel
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@ast
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@en
P2860
P921
P356
P1433
P1476
Clinical review: anticoagulati ...... t therapy--heparin or citrate?
@en
P2093
Heleen M Oudemans-van Straaten
John A Kellum
P2860
P2888
P356
10.1186/CC9358
P577
2011-01-24T00:00:00Z
P5875
P6179
1001588085